Anaptysbio (ANAB) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Anaptysbio (ANAB) over the last 12 years, with Q3 2025 value amounting to -$249.0 million.
- Anaptysbio's Enterprise Value rose 4211.9% to -$249.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$249.0 million, marking a year-over-year increase of 4211.9%. This contributed to the annual value of -$385.4 million for FY2024, which is 141.49% up from last year.
- Per Anaptysbio's latest filing, its Enterprise Value stood at -$249.0 million for Q3 2025, which was up 4211.9% from -$265.7 million recorded in Q2 2025.
- In the past 5 years, Anaptysbio's Enterprise Value ranged from a high of -$249.0 million in Q3 2025 and a low of -$548.1 million during Q4 2021
- Over the past 5 years, Anaptysbio's median Enterprise Value value was -$390.9 million (recorded in 2023), while the average stood at -$398.2 million.
- As far as peak fluctuations go, Anaptysbio's Enterprise Value tumbled by 3923.35% in 2021, and later skyrocketed by 4211.9% in 2025.
- Quarter analysis of 5 years shows Anaptysbio's Enterprise Value stood at -$548.1 million in 2021, then grew by 19.5% to -$441.2 million in 2022, then increased by 11.41% to -$390.9 million in 2023, then increased by 1.41% to -$385.4 million in 2024, then surged by 35.4% to -$249.0 million in 2025.
- Its last three reported values are -$249.0 million in Q3 2025, -$265.7 million for Q2 2025, and -$339.9 million during Q1 2025.